Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx

Blood

Volumn 91, Issue 6, 1998, Pages 1891-1900

  Gommerman, Jennifer L ^a   Berger, Stuart A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ECONAZOLE; INTERLEUKIN 3; IONOMYCIN; KETOTIFEN; PROTEIN BCL 2; STEEL FACTOR; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL SURVIVAL; DNA CONTENT; GENE EXPRESSION; GENE OVEREXPRESSION; MAST CELL; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0032520979     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1891     Document Type: Article

References (64)

1. Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
2. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
3. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387:773, 1997
4. Caceres CJ, Rajotte D, Dumouchel J, Haddad P, Hoang T: Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J Biol Chem 269:12084, 1994
5. Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
6. Hassan HT, Zander A: Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol 95:257, 1996
7. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ: The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321, 1994
8. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
9. Yee NS, Paek I, Besmer P: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 179:1777, 1994
10. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511, 1993
11. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
12. Nicotera P, Zhivotovsky B, Orrenius S: Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium 16:279, 1994
13. Dowd DR: Calcium regulation of apoptosis. Adv Second Mess Phospho Prot Res 30:255, 1995
14. Tadakuma T, Kizaki H, Odaka C, Kubota R, Ishimura Y, Yagita H, Okumura K: CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur J Immunol 20:779, 1990
15. Kizaki H, Tadakuma T, Odaka C, Muramatsu J, Ishimura Y: Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. J Immunol 143:1790, 1989
16. Ribeiro JM, Carson DA: Ca2+/Mg2+-dependent endonuclease from human spleen: Purification, properties, and role in apoptosis. Biochemistry 32:9129, 1993
17. Mercep M, Noguchi PD, Ashwell JD: The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to Cyclosporine A. J Immunol 142:4085, 1989
18. McConkey DJ, Harzell P, Amador-Perez JF, Orrenius S, Jondal M: Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol 143:1801, 1989
19. Rodriguez-Tarduchy G, Prupti M, Lopez-Rivas A, Collins MKL: Inhibition of apoptosis by calcium ionophores in IL-3-dependent bone marrow cells is dependent upon production of IL-4. J Immunol 148:1416, 1992
20. Lampe PA, Cornbrooks EB, Juhasz A, Johnson EJ, Franklin JL: Suppression of programmed neuronal death by a thapsigargin-induced Ca2+ influx. J Neurobiol 26:205, 1995
21. Columbo M, Botana LM, Horowitz EM, Lichtenstein LM, MacGlashan DJ: Studies of the intracellular Ca2+ levels in human adult skin mast cells activated by the ligand for the human c-kit receptor and anti-IgE. Biochem Pharmacol 47:2137, 1994
22. Hu Q, Trevisan M, Xu Y, Dong W, Berger SA, Lyman SD, Minden MD: c-KIT expression enhances the leukemogenic potential of 32D cells. J Clin Invest 95:2530, 1995
23. Berger SA, Mak TW, Paige CJ: Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells. J Exp Med 180:471, 1994
24. Dunn TB, Potter M: A transplantable mast cell neoplasm in the mouse. J Natl Cancer Inst 18:587, 1957
25. Rao P, Mufson RA: Human interleukin-3 stimulates a phosphatidylcholine specific phospholipase C and protein kinase C translocation. Cancer Res 54:777, 1994
26. Rottapel R, Reedijk M, Williams DE, Lyman SD, Anderson DM, Pawson T, Bernstein A: The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor. Mol Cell Biol 11:3043, 1991
27. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619, 1994
28. Penner R, Fasolato C, Hoth M: Calcium influx and its control by calcium release. Curr Opin Neurobiol 3:368, 1993
29. Franzius D, Hoth M, Penner R: Non-specific effects of calcium entry antagonists in mast cells. Pflugers Archiv Eur J Physiol 428:433, 1994
30. Liu C, Hermann TE: Characterization of ionomycin as a calcium ionophore. J Biol Chem 253:5892, 1978
31. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
32. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ: Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 151:2546, 1993
33. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
34. Schwarze MM, Hawley RG: Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262, 1995
35. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
36. Chinnaiyan AM, Dixit VM: The cell-death machine. Curr Biol 6:555, 1996
37. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Rajv SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
38. Thornberry NA, Molineaux SM: Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Prot Sci 4:3, 1995
39. Sarin A, Wu ML, Henkart PA: Different interleukin-1beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med 184:2445, 1996
40. Meisterernst M, Stelzer G, Roeder R: Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci USA 94:2261, 1997
41. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
42. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salveson GS, Dixit VM: YAMA/CPP32beta, a mammalian homolog of CED-3 is a Crm-A inhibitable protease that cleaves the death substrate poly(ADP)-ribose polymerase. Cell 81:801, 1995
43. Van de Craen M, Vandenabeele P, Declercq W, Van den Brande I, Van Loo G, Molemans F, Schotte P, Van Criekinge W, Beyaerte R, Fiers W: Characterization of seven murine caspase family members. FEBS Lett 403:61, 1997
44. Miura M, Friedlander RM, Yuan J: Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 92:8318, 1995
45. Memon SA, Moreno MB, Petrak D, Zacharchuk CM: Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. J Immunol 155:4644, 1995
46. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
47. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T cell receptor complex induce apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
48. Jones LA, Chin LT, Longo DL, Kruisbeek AM: Peripheral clonal elimination of functional T cells. Science 250:1726, 1990
49. Kovacs B, Tsokos GC: Cross-linking of the Fas/Apo-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes. J Immunol 155:5543, 1995
50. Strasser A, Harris AW, Cory S: Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
51. Franklin JL, Johnson EJ: Elevated intracellular calcium blocks programmed neuronal death. Ann NY Acad Sci 747:195, 1994
52. Franklin JL, Sanz RC, Juhasz A, Deckwerth TL, Johnson EJ: Chronic depolarization prevents programmed death of sympathetic neurons in vitro but does not support growth: Requirement for Ca2+ influx but not Trk activation. J Neurosci 15 (part 2):643, 1995
53. Shibasaki F, McKeon F: Calcineurin functions in Ca2+-activated cell death in mammalian cells. J Cell Biol 131:735, 1995
54. Bonnefoy BN, Genestier L, Flacher M, Revillard JP: The phosphoprotein phosphatase calcineurin controls calcium-dependent apoptosis in B cell lines. Eur J Immunol 24:325, 1994
55. Hallek M, Druker B, Lepisto EM, Wood KW, Ernst TJ, Griffin JD: Granulocyte-macrophage colony-stimulating factor and steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor-dependent hematopoietic cell line. J Cell Physiol 153:176, 1992
56. Herbst R, Lammers R, Schlessinger J, Ullrich A: Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase. J Biol Chem 266:19908, 1991
57. Martin U, Romer D: The pharmacological properties of a new. orally active antianaphylactic compound: Ketotifen, a Benzocycloheptathiophene. Arzneim-Forsch Drug Res 28:770, 1978
58. Grant SM, Goa KL, Fitton A, Sorkin EM: Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40:412, 1990
59. Riccardi VM: Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 123: 1011, 1987
60. Kohn EC, Sandeen MA, Liotta LA: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52:3208, 1992
61. Petrasch S, van TL, Motulsky HJ, Brodde OE, Michel MC: Effects of ketotifen on human lymphocytes in vitro and in vivo. Arzneim-Forsch Drug Res 43:904, 1993
62. Estacion M, Mordan LJ: Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influx. Cell Calcium 14:439, 1993
63. Buckley NE, Su Y, Milstien S, Spiegel S: The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin. Biochim Biophys Acta 1256:275, 1995
64. De Vries GW, McLaughlin A, Wenzel MB, Perez J, Harcourt D, Lee G, Garst M, Wheeler LA: The antiinflammatory activity of topically applied novel calcium-channel antagonists. Inflammation 19:261, 1995